Skip to main content

Animations

MJFF Publications

5351 - 5360 of 6420 Results
Title
Year
  • Year
  • 2016
  • 2019
  • 2021
  • 2016
  • 2019
  • 2020
  • 2020
  • 2021
  • 2018
  • 2017
  • Summary Details
    OPEN
    Title: Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b01780
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Deep Learning With EEG Spectrograms in Rapid Eye Movement Behavior Disorder
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2019.00806
    Citation Count: 98
  • Summary Details
    OPEN
    Title: α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28639
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Cargo proteins of plasma astrocyte‐derived exosomes in Alzheimer's disease
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1096/fj.201600756r
    Citation Count: 345
  • Summary Details
    OPEN
    Title: Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-019-0164-x
    Citation Count: 145
  • Summary Details
    OPEN
    Title: Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.25944
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.aaz9360
    Citation Count: 310
  • Summary Details
    OPEN
    Title: TNF-α and α-synuclein fibrils differently regulate human astrocyte immune reactivity and impair mitochondrial respiration
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2021.108895
    Citation Count: 49
  • Summary Details
    OPEN
    Title: VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa, cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1083/jcb.201807019
    Citation Count: 527
  • Summary Details
    OPEN
    Title: Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestry
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27059
    Citation Count: 151
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.